Adicet Bio (FRA:1IJ) FFO


FRA:1IJ Adicet Bio Inc FRA:1IJ
31 GF Score
Price €7.05
! 3 Warning Signs
View Full Analysis

What is Adicet Bio FFO?

FFO (Funds from operations) only applies to REITs.

FRA:1IJ
31GF Score
Adicet Bio Inc FRA:1IJ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adicet Bio Business Description

Other Exchanges ACET:USA0HX7:UK
Address 131 Dartmouth Street, 3rd Floor, Boston, MA, USA, 02116
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
31GF Score

Get the complete analysis for FRA:1IJ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.05
Price